Inhibition of triple negative breast cancer-associated inflammation and progression by n- acylethanolamine acid amide hydrolase (naaa)

HIGHLIGHTS

  • who: Othman Benchama from the Center of Drug Discovery, Northeastern University have published the research: Inhibition of triple negative breast cancer-associated inflammation and progression by N- acylethanolamine acid amide hydrolase (NAAA), in the Journal: Scientific Reports Scientific Reports
  • what: The authors provide data that NAAA isoforms are highly expressed in breast cancer cells as compared to normal epithelial_cells.
  • how: The following doses were examined 100 250 and 500 nM for 72 h.

SUMMARY

    The survival of tumor cells is facilitated by fatty_acid synthesis (FAS) over-expression, which provides . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?